Dr. Sherie Ma is the Chief Executive Officer of GenieUs Genomics, an early stage biotechnology company in Sydney, Australia, developing precision medicine solutions for neurodegenerative diseases. With a PhD and extensive background in neuropharmacology, genomics and genetics, Dr. Ma transitioned from an academic career research scientist to a visionary scientist-entrepreneur.

GenieUs Genomics leverages advanced genomic profiling to uncover genetic subtypes of Amyotrophic Lateral Sclerosis (ALS), a devastating motor neuron disease, to power patient stratification and responder analysis for more efficient and successful clinical trials and drug development. Dr. Ma is dedicated to transforming therapeutic development by integrating deep genetic insights into personalized treatment strategies, driving innovation to improve patient outcomes for those with MND globally.